171 related articles for article (PubMed ID: 27010147)
1. Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients.
Bilir B; Ekiz Bilir B; Yilmaz I; Soysal Atile N; Yildirim T; Kara SP; Gumustas SA; Orhan AE; Aydin M
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):892-8. PubMed ID: 27010147
[TBL] [Abstract][Full Text] [Related]
2. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.
Motawi TK; Rizk SM; Ibrahim IA; El-Emady YF
Cell Biochem Funct; 2014 Mar; 32(2):155-63. PubMed ID: 23913471
[TBL] [Abstract][Full Text] [Related]
3. Endocan and albuminuria in type 2 diabetes mellitus.
Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
[TBL] [Abstract][Full Text] [Related]
4. Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.
Dallio M; Masarone M; Caprio GG; Di Sarno R; Tuccillo C; Sasso FC; Persico M; Loguercio C; Federico A
J Gastrointestin Liver Dis; 2017 Sep; 26(3):261-268. PubMed ID: 28922438
[TBL] [Abstract][Full Text] [Related]
5. Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients.
Hosny SS; Nasr MS; Ibrahim RH; YousryHelal Z
Diabetes Metab Syndr; 2019; 13(1):626-629. PubMed ID: 30641779
[TBL] [Abstract][Full Text] [Related]
6. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke.
He XW; Ke SF; Bao YY; Hong WJ; Shen YG; Li C; Zhu F; Wang E; Jin XP
Clin Chim Acta; 2018 Mar; 478():157-161. PubMed ID: 29287901
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
[TBL] [Abstract][Full Text] [Related]
9. Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.
Balamir I; Ates I; Topcuoglu C; Turhan T
Angiology; 2018 Aug; 69(7):609-616. PubMed ID: 29172652
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus.
Ekiz-Bilir B; Bilir B; Aydın M; Soysal-Atile N
Arch Med Sci; 2019 Jan; 15(1):86-91. PubMed ID: 30697257
[TBL] [Abstract][Full Text] [Related]
11. Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes: A Preliminary Study.
Arman Y; Akpinar TS; Kose M; Emet S; Yuruyen G; Akarsu M; Ozcan M; Yegit O; Cakmak R; Altun O; Aydin S; Alibeyoğlu A; Ugurlu B; Akcan T; Tukek T
Angiology; 2016 Mar; 67(3):239-44. PubMed ID: 25969567
[TBL] [Abstract][Full Text] [Related]
12. Associations of Serum S100B and S100P With the Presence and Classification of Diabetic Peripheral Neuropathy in Adults With Type 2 Diabetes: A Case-Cohort Study.
Afarideh M; Zaker Esteghamati V; Ganji M; Heidari B; Esteghamati S; Lavasani S; Ahmadi M; Tafakhori A; Nakhjavani M; Esteghamati A
Can J Diabetes; 2019 Jul; 43(5):336-344.e2. PubMed ID: 30872108
[TBL] [Abstract][Full Text] [Related]
13. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
14. Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus.
Klisic A; Kavaric N; Vujcic S; Mihajlovic M; Zeljkovic A; Ivanisevic J; Spasojevic-Kalimanovska V; Ninic A; Kotur-Stevuljevic J; Vekic J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8127-8135. PubMed ID: 32767341
[TBL] [Abstract][Full Text] [Related]
15. Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.
Aciksari G; Kavas M; Atici A; Kul S; Erman H; Yilmaz Y; Demircioglu K; Yalcinkaya E; Kanbay A; Caliskan M
Angiology; 2018 Nov; 69(10):878-883. PubMed ID: 29747515
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Serum Endothelial Cell-Specific Molecule 1 (Endocan) Level in Type 2 Diabetes Mellitus With Acute ST-Segment Elevation Myocardial Infarction and its Correlation: A Pilot Study.
Qiu CR; Fu Q; Sui J; Zhang Q; Wei P; Wu Y; Zhu K; Lu Y; Wan P
Angiology; 2017 Jan; 68(1):74-78. PubMed ID: 26927690
[TBL] [Abstract][Full Text] [Related]
17. Endocan: a new biomarker associated with inflammation in type 2 diabetes mellitus?
Rodrigues KF; Pietrani NT; Bosco AA; Sousa LP; Ferreira CN; Sandrim VC; Gomes KB
Diabetes Metab Res Rev; 2015 Jul; 31(5):479-80. PubMed ID: 26147320
[No Abstract] [Full Text] [Related]
18. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
Erdem G; Dogru T; Tasci I; Sonmez A; Tapan S
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):289-92. PubMed ID: 18484561
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.
Kallestrup M; Møller HJ; Tankisi H; Andersen H
Diabet Med; 2015 Jan; 32(1):54-61. PubMed ID: 25156085
[TBL] [Abstract][Full Text] [Related]
20. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
Pawlak K; Mysliwiec M; Pawlak D
Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
